UroGen Pharma Ltd., a biotech company specializing in urothelial and specialty cancers, announced it will present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference on November 10, 2026. The presentation includes a fireside chat and investor meetings in Boston, with a webcast available on UroGen's website. UroGen is known for its RTGel sustained-release technology and approved products treating urothelial cancers non-surgically. This event highlights UroGen's ongoing efforts to innovate cancer treatment and engage with investors.
UroGen Pharma's upcoming presentation at the Guggenheim Securities Healthcare Innovation Conference provides context for readers following healthcare stocks. For readers following health-sector US stocks on Pluang, here is the market snapshot as of Nov 03, 2026 20:11 WIB: out of 150 priced stocks, 75 rose and 69 fell. Notable movers include RLAY at USD 17.79 with a 1-day change of +2.95%, BKD at USD 10.16 with -2.68%, and VRTX at USD 565.98 with +2.32%, where VRTX also shows Pluang order activity of 25% Sell and 75% Buy and a typical hold time of 123 days.
The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
